Michael Schieber

Northwestern Medicine Lake Forest Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome”.

FBXO11 is a candidate tumor suppressor in the leukemic transformation of myelodysplastic syndrome

Blood Cancer Journal(2020)10.1038/s41408-020-00362-7

N/A

0.529DataRank · unranked

33 citations

Christian Marinaccio, Lyndsey Bolanos, Wendy D. Haffey, Kenneth D. Greis, Daniel T. Starczynowski +2 more

LKB1/ STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1353

N/A

0DataRank · unranked

46 citations

Praveen Suraneni, Hamza Celik, Andrew Volk, Qiang Wen, Te Ling +20 more

Targeting SLFN11-regulated pathways restores chemotherapy sensitivity in AML

Blood Neoplasia(2024)10.1016/j.bneo.2024.100037

N/A

0DataRank · unranked

2 citations

Ricardo E. Perez, Elspeth M. Beauchamp, Aneta Baran, Stephen D. Willis, Mariafausta Fischietti +5 more

Schlafen 12 Modulation and Targeting in Acute Myeloid Leukemia

Cancer Research Communications(2025)10.1158/2767-9764.crc-25-0283

N/A

0DataRank · unranked

0 citations

Μαρκέλλα Ζαννίκου, Aneta Baran, Sara Small, Michael Schieber, Matthew J. Schipma +7 more